T1DM and T2DM; in vivo (B6 mice), in vitro (MIN6-B1*, INS-1* cell lines)  STZ-induced DM (low-dose and high-dose models) • Lipotoxicity. Here, FOXM1 is linked to type 2 diabetes mellitus.